Beta-Nicotinamide Mononucleotide β-烟酰胺单核苷酸
CAS 1094-61-7 MFCD00038748
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- Bases & Related Reagents
- {SNA} Cofactors, Oxidation-Reduction, 生化试剂, 酶、抑制剂和底物
- Nucleotides
- Nicotine Derivatives
- Pharmaceuticals
- Amines
- Aromatics
- Intermediates & Fine Chemicals,
- {SNA} Biochemicals and Reagents, Cofactors, Enzymes, Inhibitors, and Substrates, Oxidation-Reduction
产品应用
- ########
相关文献及参考
- [2]. Lv H, et al. NAD+ Metabolism Maintains Inducible PD-L1 Expression to Drive Tumor Immune Evasion [published online ahead of print, 2020 Nov 3]. Cell Metab. 2020;S1550-4131(20)30554-4.
- [3]. Li J, et al. p53 prevents doxorubicin cardiotoxicity independently of its prototypical tumor suppressor activities. Proc Natl Acad Sci U S A. 2019;116(39):19626-19634.
- [4]. Yoshino J, et al Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 2011;14(4):528-536.
- Yoshino, J. et al.: Cell Metab., 14, 528 (2011); Caton, P.W. et al.: Diabetologia, 54, 3083 (2011); Formentini, L. et al.: BIochem. Pharmacol., 77, 1612 (2009);
- [1]. Poddar SK, et al. Nicotinamide Mononucleotide: Exploration of Dive
- [1]. Poddar SK, et al. Nicotinamide Mononucleotide: Exploration of Diverse Therapeutic Applications of a Potential Molecule. Biomolecules. 2019;9(1):34. Published 2019 Jan 21.
安全信息
GHS Symbol